Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial

Table 8

Proportion of asymptomatically infected subjects with positive nucleic acid tests.

Follow-up timepoint	Symptomaticity	N = 13		value
		LH group; (N = 3)	Control group; (N = 10)
Isolation period	Asymptomatic infection, N (%)	3 (100.00)	9 (90.00)	1.0000
	Symptomatic infection, N (%)	0 (0.00)	1 (10.00)